| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/28/2007 | CA2634147A1 Calcium channel antagonists |
| 06/28/2007 | CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs |
| 06/28/2007 | CA2631991A1 Heterocyclic gaba-b modulators |
| 06/28/2007 | CA2631347A1 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/28/2007 | CA2631148A1 Pestcidal compositions |
| 06/28/2007 | CA2628596A1 Estrogen modulators |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/27/2007 | EP1801165A2 Modified carbocyanine dyes and their conjugates |
| 06/27/2007 | EP1801108A1 Morpholine compound |
| 06/27/2007 | EP1800682A1 Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 06/27/2007 | EP1799690A1 Thiazolyl-dihydro indazoles |
| 06/27/2007 | EP1799678A1 Process for preparing ziprasidone |
| 06/27/2007 | EP1799677A1 Oxazolidinone derivatives as antimicrobials |
| 06/27/2007 | EP1799674A1 New piperidine antibiotics |
| 06/27/2007 | EP1799661A1 New hydroxymethylbenzothiazoles amides |
| 06/27/2007 | EP1799652A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 06/27/2007 | EP1740574B1 4-amino-5-cyanopyrimidine derivatives |
| 06/27/2007 | EP1727815B1 Ether derivatives, their manufacture and use as pharmaceutical agents |
| 06/27/2007 | EP1567525B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1485376B1 Compositions useful as inhibitors of protein kinases |
| 06/27/2007 | EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides |
| 06/27/2007 | CN1989139A Benzothiazole derivatives |
| 06/27/2007 | CN1989138A 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders |
| 06/27/2007 | CN1989131A Substituted thiophene derivatives as anti-cancer agents |
| 06/27/2007 | CN1989128A New 4-benzylidene-piperidin derivatives |
| 06/27/2007 | CN1989122A Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 06/27/2007 | CN1989104A Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 06/27/2007 | CN1988906A Acylated piperidine derivatives as melanocortin 4-receptor agonists |
| 06/27/2007 | CN1986533A Preparation and application of alkenyl amide cluster compound |
| 06/26/2007 | US7235669 Epothilone side components |
| 06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 06/26/2007 | US7235656 Anxiolytic agents with reduced sedative and ataxic effects |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235572 Thiazolyl-indole derivatives, their manufacture and use as pharmaceutical agents |
| 06/26/2007 | US7235571 Insecticides; for human or veterinary medicine |
| 06/26/2007 | US7235570 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235562 5-trifluoromethyl-N2-indolyl- and quinolinyl-substituted-2,4-pyrimidinediamines, e.g., N2-[3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-N4-p-tolyl-5-trifluoromethyl-pyrimidine-2,4-diamine and -[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-3,4-dihydro-1H-quinolin-2-one |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235558 Anticoagulant; cardiovascular disorders; restenosis |
| 06/26/2007 | US7235548 Central nervous system disorders; cognition activators; Alzheimer's disorders; stroke |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/26/2007 | US7235545 (Calcitonin gene related peptide); azepinone ligands; migranes; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 06/26/2007 | US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 06/21/2007 | WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | WO2007070433A2 2-arylthiazole derivatives as cxcr3 receptor modulators |
| 06/21/2007 | WO2007070398A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | WO2007070201A1 Aspartic protease inhibitors |
| 06/21/2007 | WO2007069773A1 A pharmaceutical composition comprising an amide derivative |
| 06/21/2007 | WO2007069669A1 Pharmaceutical composition for enhancing adiponectin production |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007068375A1 Carboxamides for controlling undesired micro-organisms in plant protection |
| 06/21/2007 | WO2007048064A3 Amino-pyrimidines as casein kinase ii (ck2) modulators |
| 06/21/2007 | WO2007042544A3 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 06/21/2007 | WO2007030567A3 Pparactive compounds |
| 06/21/2007 | WO2007022380A3 Bis-aryl amide compounds and methods of use |
| 06/21/2007 | US20070142675 Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 06/21/2007 | US20070142634 phenylamide and pyridylamide derivative compounds having a terminal or branched amino or hydroxyl group |
| 06/21/2007 | US20070142453 1-Alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditions |
| 06/21/2007 | US20070142446 (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor |
| 06/21/2007 | US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia |
| 06/21/2007 | US20070142437 Chemical compounds |
| 06/21/2007 | US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 06/21/2007 | US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases |
| 06/21/2007 | US20070142390 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 06/21/2007 | US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 06/21/2007 | US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142373 Quinoline derivatives as phosphodiesterase inhibitors |
| 06/21/2007 | US20070142371 Anti-Cytokine Heterocyclic Compounds |
| 06/21/2007 | US20070142368 N4-(2-methoxyethyl)-N6-(5methyl-1H-pyrazol-3-yl)-2-styrylpyrimidine-4,6-diamine; Aurora protein kinase inhibitors; anticarcinogenic agents; antitumor agents; antimetastatic agents; melanoma, lymphoma, leukemia; cancer of the colon, colorectum, breast, lung, kidney, pancreas, kidney, stomach; ovaries |
| 06/21/2007 | US20070142365 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC |
| 06/21/2007 | US20070142360 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142349 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070142300 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 06/21/2007 | US20070142245 E.g., bis(1,2,3,4-tetrahydroquinolin-8-yl)amine, bis(2,3-dihydro-1-benzofuran-5-yl)amine and bis(1,3-benzodioxol-5-yl)amine; oil soluble and serve as antioxidants, antiozoants, heat stabilizers and ultraviolet light stabilizers |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070140962 Light Sensitive Compounds for Instant Determination of Organ Function |
| 06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
| 06/21/2007 | DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug |
| 06/21/2007 | CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 06/21/2007 | CA2633569A1 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | CA2633023A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | CA2631051A1 Organic compounds |
| 06/21/2007 | CA2628952A1 Aspartic protease inhibitors |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798216A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same |
| 06/20/2007 | EP1797878A2 Benzothiazole derivatives |
| 06/20/2007 | EP1797100A1 Nitrate esters and their use for mitigating cellular damage |